ATS 2019 Virtual Final Program

P36 Can Historical Electronic Health Record Smoking Data Be Leveraged to Improve the Selection of Patients for Lung Cancer Screening?/ D.J. Kats, A. Tlimat, Y. Adie, Y. Tarabichi, Cleveland, OH, p.A3049 P37 Development and Validation of an Algorithm to Identify Chronic Obstructive Pulmonary Disease in Individuals Eligible for Lung Cancer Screening/ D. Ha, C. Zeng, A. Burnett-Hartman, B. Hixon, C.A. Joyce, D.P. Ritzwoller, Aurora, CO, p.A3050 P38 Determinants of Cancer-Specific Quality of Life in Veteran Lung Cancer Survivors Eligible for Long-Term Cure/ D. Ha, J.J. Swigris, Aurora, CO, p.A3051 Facilitator : M. Triplette, MD, MPH, Seattle, WA P39 Chasing the Nationally Under Screened Cancer: A Quality-Improvement Project to Increase Lung Cancer Screening in a Resident-Run Outpatient Clinic/ K. Vijaykumar, J. Hanna, J. Lenka, A. Mohamed, A. Waktola, C. Thannikkotu, A. Zafar, Rochester, NY, p.A3052 P40 Implementation of a Standardized Template for Reporting of Incidental Pulmonary Nodules: A Mixed Methods Study/ A.C. Melzer, A. Aase, A.E. Fabbrini, S. Averill, K. White, Minneapolis, MN, p.A3053 P41 A Novel Model-Based Questionnaire for COPD Diagnosis Based on Data of Low-Dose CT Screening in Shimane, Japan/ A. Tanino, T. Kawamura, M. Hamaguchi, R. Tanino, M. Kobayashi, J. Umemoto, Y. Shiratsuki, T. Okuno, M. Nakao, Y. Amano, T. Hotta, T. Okimoto, Y. Tsubata, S. Hamaguchi, N. Kurimoto, T. Isobe, Izumo, Japan, p.A3054 P42 A Year in Review: Identifying Delays in Lung Cancer Diagnosis/ P. Patel, R.M. Davis, P.E. Whitten, Peoria, IL, p.A3055 P43 A Cost-Effectiveness Analysis on a Bronchial Genomic Classifier for the Diagnosis of Lung Cancer/ E. D’Andrea, N.K. Choudhry, B.A. Raby, G.L. Weinhouse, M. Najafzadeh, Boston, MA, p.A3056 P44 Lung Cancer in Young Patients. Tumour Characteristics and Treatment in a Single Centre/ S. Cullivan, S. Ni Mhaolcatha, N.K. Muhammad, W. Mullally, R.M. Bambury, L. Burke, M.P. Kennedy, Cork, Ireland, p.A3057 P45 Radiation Pneumonitis: Outcomes and Predictors of Mortality Using a Large Inpatient Database/ S. Godara, N. Siddiqui, A. Godara, A.O. Soubani, Detroit, MI, p.A3058 CLINICAL THEMATIC POSTER SESSION B39 GRANULOMATOUS ILDs 9:15 a.m. - 4:15 p.m. KBHCCD Area B (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : A.S. Morgenthau, MD, New York, NY P147 Acceptability and Efficacy of a mHealth App for Sarcoidosis Associated Fatigue/ W.E. James, J. Chandler, B. Brunner-Jackson, L. Sox, M. Swem, A. Neely, F. Treiber, Charleston, SC, p.A3059 P148 Development of a Patient Centered Thematic Framework for Experiences Living with Chronic Hypersensitivity Pneumonitis; A Qualitative Study/ K.I. Aronson, B.J. Hayward, L. Robbins, R.J. Kaner, F.J. Martinez, M. Safford, New York, NY, p.A3060 P149 Transbronchial Biopsy in Chronic Hypersensitivity Pneumonitis/ A.B. Botelho, R.G. Ferreira, M.T. Cerezoli, R.B. Martins, P. Gomes, A. Gimenez, M.R. Soares, C.A.D.C. Pereira, Sao Paulo, Brazil, p.A3061 P150 Antigen Avoidance Test Is Beneficial for Predicting The Prognosis of Patients with Chronic Hypersensitivity Pneumonitis Treated with Corticosteroid Therapy/ S. Hanzawa, T. Tateishi, T. Kawahara, M. Ishizuka, Y. Miyazaki, Bunkyo-ku, Tokyo, Japan, p.A3062 P151 Clinical and Radiological Features That Are Used to Distinguish Chronic Hypersensitivity Pneumonitis from Idiopathic Pulmonary Fibrosis/ A. Wong, C.J. Hague, J.L. Wright, A.M. Churg, C.J. Ryerson, Vancouver, Canada, p.A3063 P152 Efficacy of Infliximab Therapy in Cardiac Sarcoidosis: A Single Center Case Series/ O. Sinokrot, S. Pan, A. Reyentovich, D.J. Addrizzo-Harris, New York, NY, p.A3064 P153 Utility of Rapid On-Site Evaluation on Endobronchial Ultrasound Guided Transbronchial Needle Aspirate of the Mediastinal and Hilar Lymph Nodes in Patients with Sarcoidosis/ V. Pathak, P. Panchatsharam, C. Walker, J. Casale, S. Jha, C.Y. Zhou, Raleigh, NC, p.A3065 P154 The Correlation Between PET Scan Findings and Fatigue in Sarcoidosis/ V. Mihailovic-Vucinic, M. Stjepanovic, B.A. Milenkovic, S.D. Filipovic, B. Gvozdenovic, Belgrade, Serbia, p.A3066 P155 Anti-Fibrotic Therapy for Chronic Hypersensitivity Pneumonitis: Don’t Forget the Antigen/ N. Boctor, J.V. Pugashetti, R.W. Harper, B.M. Morrissey, J. Oldham, Sacramento, CA, p.A3067 P156 Causes of Hypersensitivity Pneumonitis: Literature Review and Development of a Knowledge Translation Tool/ J. Lu, H. Barnes, J. Morisset, K.A.M. Johannson, Calgary, Canada, p.A3068 P157 Comparison of Thoracic Sarcoidosis Stage Determined from the Presentations of Chest X-Ray Versus High-Resolution Computed Tomography and Application in Both Chinese and American Patients with Sarcoidosis/ D. Weng, H. Li, Shanghai, China, p.A3069 Facilitator : D.C. Patel, DO, MBA, Gainesville, FL P158 The Correlation of a Sarcoidosis Clinical Outcome Score to Patient Demographics and Sarcoidosis Organ Involvement/ K. Hu, R. Reeves, J.M. Zeigler, M.A. Judson, D.A. Culver, N. Sweiss, E.S. Chen, N.Y. Hamzeh, J.C. Grutters, D. Valeyre, G. Spitzer, R.P. Baughman, Albany, NY, p.A3070 ATS 2019 • Dallas, TX 152 MONDAY • MAY 20